RxDoctor Payments Data

Matthew Barnes, PA

Medical · Gainesville, FLNPI 1801198635

Payments from drug & device makers

$879in general payments, 2019–2025

Across 37 payments — averaging $23.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$253
  • Inspire Medical Systems, Inc.$146
  • AstraZeneca$85
  • Regeneron Healthcare Solutions, Inc.$64
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • Sanofi$33
  • plus $242 from 11 others

What the payments were for

  • Food & beverage$879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$879 in reported general payments places this provider in the 50th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$18,573
Medicare patients
108
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$60,689
NucalaMepolizumab11$39,080
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$16,846
Spiriva HandihalerTiotropium Bromide22$12,572
Breo ElliptaFluticasone/Vilanterol21$10,521
SymbicortBudesonide/Formoterol Fumarate26$10,479
Advair HfaFluticasone Propion/Salmeterol18$5,912
Incruse ElliptaUmeclidinium Bromide14$5,359
Albuterol Sulfate HfaAlbuterol Sulfate95$3,762
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,770
Ventolin HfaAlbuterol Sulfate35$2,112
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$760
Azelastine Hcl34$655
Montelukast Sodium40$569
Fluticasone Propionate28$466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Nucala, Breo Ellipta, Incruse Ellipta$253$115,648111 claims
AstraZenecaBreztri Aerosphere, Symbicort$85$27,32547 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,031 medical providers in Florida.

Other medical in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →